European Parliament 21 May 2012, Written question E-005111/12 Mara Bizzotto (EFD) to the Commission. Insight into Nimesulide

Question for written answer E-005111/12 to the Commission Mara Bizzotto (EFD) (21 May 2012) Subject: Insight into Nimesulide In 2002, Finland and Spain withdrew medicines using Nimesulide as their active ingredient from the market. A similar move was made by Ireland in 2007 following a decision by the Irish Medicines Board.